Vividion Therapeutics to Expand with New Global Research and Development Center

New facility in San Diego will support continued development of Vividion’s global discovery and clinical portfolio and pave the way for future programs aimed at bringing first-in-class therapeutics to patients in need Chemoproteomics screening capacity will increase by 50 percent to enable Vividion to pursue an expansive range of previously undrugged disease targets SAN DIEGO–(BUSINESS … [Read more…]

Australian Medtech EMVision Unveils Backpack-Sized Brain Scanner to Empower First Responders

Company’s second-generation device further miniaturises its portable brain scanner technology to tackle the global burden of stroke SYDNEY–(BUSINESS WIRE)–EMVision (ASX: EMV), an Australian medical device company focused on the development and commercialisation of innovative portable brain scanning technology, has today unveiled its First Responder Proof of Concept device, designed for deployment via road and air … [Read more…]

AIDS is Still Not Over, says AHF

LOS ANGELES–(BUSINESS WIRE)–As the International AIDS Conference gets underway this week in Munich, Germany, AIDS Healthcare Foundation reminds the world that AIDS is not over amid slowing progress on the pandemic and stubbornly high global mortality. “Despite four decades of hard-won progress against HIV/AIDS, a staggering number of people still die of AIDS-related causes – … [Read more…]

Delcath Systems to Host Second Quarter 2024 Earnings Call

QUEENSBURY, N.Y.–(BUSINESS WIRE)–Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on August 5, 2024, at 4:30 PM Eastern Time to discuss results for its second quarter ended June 30, 2024. Conference Call Information To … [Read more…]

Lawyers for Ovarian Cancer Victims Urge NO Vote on J&J’s Latest Bankruptcy Plan

Beasley Allen, Levin Papantonio, and coalition of law firms cite misleading efforts to secure approval TRENTON, N.J.–(BUSINESS WIRE)–Thousands of individuals who are being told they may be eligible for quick and significant compensation from a proposed $6.5 billion bankruptcy settlement offered by Johnson & Johnson (NYSE:JNJ) are being misled, according to other attorneys who represent … [Read more…]

PharmaEssentia Appoints Beth A. Krewson as Head of Legal

BURLINGTON, Mass.–(BUSINESS WIRE)–PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced the appointment of Beth A. Krewson as Head of Legal. Krewson is a legal and compliance leader in the … [Read more…]

Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), has been awarded the first tranche of a two year cooperative grant of up to approximately $1.9 million from the National Institute on Drug Abuse (“NIDA”), part of the … [Read more…]

Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central Asia

– RADIAN’s Five-Year, $25 Million Extension Will Increase Support for Local Organizations and Drive Progress to Help Turn the Tide on HIV Across the Region – – RADIAN Will Expand Geographic Focus to Provide Key Populations and Communities Impacted by the Conflict in Ukraine with HIV Prevention and Care Services – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead … [Read more…]

Apollo Therapeutics and the University of Oxford Enter Into Drug Discovery and Development Collaboration

Apollo Therapeutics will inject capital and expertise into pipeline of potentially lifesaving medicines through an agreement with the University of Oxford. Collaboration highlights a shared strategic intent to develop new therapeutics based on breakthroughs in biology and basic medical research at the University of Oxford. OXFORD, England & BOSTON–(BUSINESS WIRE)–The University of Oxford (“Oxford”), one … [Read more…]

Prime Healthcare Services, Inc. Schedules 2024 2nd Quarter Earnings Conference Call

ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare Services will host a conference call to provide a business update and review 2024 second quarter results on August 6th at 2:00 p.m. (ET). To pre-register for the call, please email EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. For those who do not … [Read more…]